ST
EGRX

Spot Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Spot Trading’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$100K Buy
+1,669
New +$101K ﹤0.01% 2543
2016
Q1 		– Sell
-2,139
Closed -$136K – 4102
2015
Q4 		$190K Buy
+2,139
New +$169K ﹤0.01% 2506

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Spot Trading's EGRX Position: Q3 2017 in Review

Spot Trading opened a new position in Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2017: 1,669 shares worth $100K. The stake represents ﹤0.01% of the portfolio and ranks #2543 among its holdings. This is a return to the name: Spot Trading previously reported a position in EGRX as recently as Q4 2015.

Spot Trading first reported a position in EGRX in Q4 2015 and has held it in 2 quarters since. The position peaked at $190K in Q4 2015. 169 funds tracked by Wall St. Rank hold EGRX as of Q3 2017.

  • Spot Trading held 1,669 shares of Eagle Pharmaceuticals, Inc. worth $100K as of Q3 2017.
  • Eagle Pharmaceuticals, Inc. was a new Spot Trading position in Q3 2017.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2543 holding.
  • Spot Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2015 and has held it in 2 quarters since.
  • Spot Trading's Eagle Pharmaceuticals, Inc. position peaked at $190K in Q4 2015.
  • 169 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.